Identification |
Name: | Eletriptan hydrobromide |
Synonyms: | 1H-Indole,3-[(1-methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-,monohydrobromide, (R)-;1H-Indole,3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-,monohydrobromide (9CI);(R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indolehydrobromide;1H-Indole,3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-,hydrobromide (1:1);Relert;Relpax;UK 116044-04; |
CAS: | 177834-92-3 |
Molecular Formula: | C22H27BrN2O2S |
Molecular Weight: | 463.43 |
InChI: | InChI=1/C22H26N2O2S.BrH/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20;/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3;1H/t19-;/m1./s1 |
Molecular Structure: |
|
Properties |
Appearance: | Tan solid |
Specification: |
?Eletriptan hydrobromide (CAS NO.177834-92-3)?is also named as Eletriptan ; (R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide ; 3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole, monohydrobromide ; Relpax ; UK 116044-04 ; UNII-M41W832TA3 ; 1H-Indole, 3-(((2R)-1-methyl-2-yrrolidinyl))methyl)-5-(2-(phenylsulfonyl)ethyl)-, monohydrobromide .
|
Biological Activity: | Orally active, selective 5-HT 1B/1D receptor agonist. Produces a dose-dependent reduction in carotid artery blood flow in vivo . Displays antimigraine activity. |
Safety Data |
|
|